AVTOZMA Q Code: Q5156
Injection, tocilizumab-anoh (avtozma), biosimilar, 1 mg
Drug & Product Overview
About AVTOZMA
Avtozma is a medication aligned to the HCPCS Q Code: Q5156 for billing, pricing, and reimbursement purposes in the United States. This Immunology: Anti-TNF medication is administered via the intravenous or subcutaneous routes and manufactured by multiple companies.
Manufacturers, reach out to us to add more information.
NDC Code Information
Based on publicly available CMS files. Showing 3 of 5 NDCs — log in for the full crosswalk.
| NDC Code | Drug | Manufacturer | Billing Units / Pkg | Package Size |
|---|---|---|---|---|
| 72606-0042-01 | Avtozma | CELLTRION USA, Inc. | 80 | 80 MG / 4 ML |
| 72606-0043-01 | Avtozma | CELLTRION USA, Inc. | 200 | 200 MG / 10 ML |
| 72606-0044-01 | Avtozma | CELLTRION USA, Inc. | 400 | 400 MG / 20 ML |
| •••••-••••-•• Log in to view | AVTOZMA | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
| •••••-••••-•• Log in to view | AVTOZMA | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
AVTOZMA Pricing & Reimbursement
National median reimbursement across major commercial payers.
Create an account on PayerPrice for more information →
Historical Graphing and Billing Calculator
Log in to calculate billing and reimbursement with live ASP, WAC & AWP pricing.
Login to use the calculator →Tocilizumab Biosimilar Information:
AVTOZMA Approval Date: January 24, 2025
| Product Name | HCPCS Code | Active Ingredient | BLA Type |
|---|---|---|---|
| Actemra | J3262 | Tocilizumab | 351(a) Originator Product |
| Tofidence | Q0234 | Tocilizumab | 351(k) Biosimilar |
| Avtozma | Q0237 | Tocilizumab | 351(k) Interchangeable |
| Tyenne | Q0238 | Tocilizumab | 351(k) Biosimilar |
| Tofidence | Q5133 | Tocilizumab | 351(k) Biosimilar |
| Tyenne | Q5135 | Tocilizumab | 351(k) Biosimilar |
| Avtozma | Q5156 | Tocilizumab | 351(k) Interchangeable |
AVTOZMA CPT Administration Codes
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| CPT Code | Description |
|---|---|
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure) |
This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →
AVTOZMA Clinical Information
Indications and drug classification.
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Try Pro free for 7 daysUpgrade to ProAdd Analytics and full history with ProComparative Report
Compare AVTOZMA with ACTEMRA and its biosimilars
- AVTOZMA Q5156
- ACTEMRA J3262
- Tofidence Q0234
- Avtozma Q0237
- TOFIDENCE Q5133
- Tyenne Q0238
ASP, the Medicare payment limit, WAC and AWP for all 6 drugs on one timeline, with 10+ years of monthly history.
Card required · cancel anytime
Frequently Asked Questions
Is there an available Avtozma billing and coding guide?
Are there any available Avtozma patient assistance programs?
Where can I find Avtozma prescribing information?
Where can I find Avtozma side effect information?
Does billing Avtozma require wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to AVTOZMA.